Mereo BioPharma Group (MREO)
Mereo BioPharma Max Pain By Strike
MREO trades at $1.77, 77.0% above the near-term max pain of $1 expiring Sep 19, 2025 (11 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($0.5-$7), signaling increased put positioning or downside protection. Key magnetic zone at 1 where 3 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Mereo BioPharma Max Pain By Expiry
Max pain for MREO shows a downward trend from 7 to 0.5, indicating bearish sentiment or hedging activity. The 289% spread signals divergent expectations across timeframes. Levels distributed around 1.77. Strong magnetic level at 1 (3 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Sep 19, 2025 | 1 | -0.77 (-43.50%) |
| Oct 17, 2025 | 0.5 | -1.27 (-71.75%) |
| Nov 21, 2025 | 2 | 0.23 (12.99%) |
| Dec 19, 2025 | 2 | 0.23 (12.99%) |
| Jan 16, 2026 | 7 | 5.23 (295.48%) |
| Feb 20, 2026 | 1 | -0.77 (-43.50%) |